Buehlmann


genetic disorders

Just a sample image

AutoGenomics

The company's mission is to empower clinical laboratories with an automated multiplexing MDx solution to perform molecular testing that will significantly enhance work flow, cost efficiency and turn-around time resulting in enhanced patient care.

Cystic Fibrosis

test

The Cystic Fibrosis Transmembrane Regulator (CFTR) is a protein coded by the CF gene to regulate chloride channels within cells. Over 1300 variants have been identified, however most are extremely rare at less than 0.1%. Severity of CF disease varies widely with different genetic variants.
On the INFINITI® CFTR31 test 25 genetic mutations and 6 reflex tests (ACMG & ACOG CF-panel) are determined.
Other INFINITI® genetic disorder tests are FII, FV, MTHFR, FII-FV Panel, FII-FV-MTHFR Panel and the Ashkenazi Jewish Panel.

downloads

Factor II

[PDF 800KB]

Factor V

[PDF 800KB]

Factor II - Factor V

[PDF 800KB]

MTHFR (Methylenetetrahydrofolate Reductase)

[PDF 800KB]

Factor II - Factor V - MTHFR 

[PDF 800KB]

CFTR31 (Cystic Firbosis)

[PDF 800KB]

CFTR15 (Cystic Firbosis)

[PDF 800KB]

Ashkenazi Jewish Panel

[PDF 800KB]

Familial Mediterranean Fever (FMF)

[PDF 800KB]

Apo E

[PDF 800KB]

 

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

The recently launched EntroGen BRAF (V600E/K/D) test, that can be run on your real-time PCR instrument, is now CE-IVD marked

The EntroGen BRAF (V600E/K/D) test is a very useful tool for the detection of important mutations found in melanoma, because it detects, beside the V600E  more

INFINITI KRAS-BRAF study from the Basel Institut of Pathology published in the Diagnostic Molecular Pathology journal.

New publication about the INFINITI KRAS assay in the Journal Diagn Mol Path 21/1 2012 14-23, Bihl et al. In this study from the Institute of Pathology at  more

Recent publications on BÜHLMANN calprotectin assays

Three very interesting new papers have been published recently. Manz et al. describes the quality and usefulness of the BÜHLMANN calprotectin ELISA in an  more

NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND

BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb  more

Get our RSS - Feed